v0251
Gene therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01583738)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Translocator proteinSupplementation
TSPO supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- v0251
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01583738 | Phase 2 | Apr 1, 2012 | Pierre Fabre |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pierre Fabre | For profit | 1 | 1 | 1 | 2012 |
1 organizations
Page 1 / 1